AI assistant
Sending…
CONMED Corp — Director's Dealing 2021
May 4, 2021
31971_dirs_2021-05-04_27d6eebb-2500-4a71-94a8-c3872862d7af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-04-30
Reporting Person: Cohen Heather L (EVP CORP HR)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-30 | Common Stock | M | 10000 | $26.09 | Acquired | 34456 | Direct |
| 2021-04-30 | Common Stock | F | 5383 | $140.95 | Disposed | 29073 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-30 | Sars (Stock Appreciation Rights) | $26.09 | M | 10000 | Disposed | 2022-06-01 | Common Stock (10000) | Direct |
Footnotes
F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
More from CONMED Corp
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18